DiseaseINFOPACK: Clostridium difficile in China

Published by: VacZine Analytics

Published: Nov. 1, 2009 - 35 Pages

Table of Contents

Executive summary

Introduction

Research Methodology

About the Author

Awareness of C.diff in China

Incidence and disease trends

Part I: Reports published in international English journals

Part II: Reports published in Chinese language journals

Part IIa: C.diff infection incidence among general inpatient populations

Part IIb: C.diff infection incidence among specific inpatient populations

Part III: Summary viewpoint(s) after discussion with local physicians

C.diff relapse rate and China

C.diff severity and China

C.diff risk factors and China - underlying comorbidities

C.diff risk factors and China - use of broad spectrum antibiotics

C.diff risk factors and China - host immune status

C.diff risk factors and China - residence in nosocomial setting

C.diff and current treatments in China

C.diff and endemic strains in China

Comments on economic burden of C.diff infection in China

Identified local and national experts in C.diff and/or hospital infections

Bibliography

About VacZine Analytics

Disclaimer

Abstract

Clostridium difficile (C.diff) is a Gram-positive bacterium, which in vulnerable hospitalized patients can cause mild uncomplicated diarrhea to severe-complicated disease where patients experience fever, tachycardia and psuedomembranous colitis. While information and literature pertaining to C.diff epidemiology is accumulating in Western markets, a lot less is known in large emerging nations such as China. Information is required to understand whether the extent of disease epidemiology and associated dynamics is similar to the West, and which steps need to be taken in order to accurately assess current disease burden.

This DiseaseINFOPACK is a comprehensive up-to-date review of current literature, also capturing the viewpoint of local physicians. It is designed to support the information gathering of commercial manufacturers of C.diff related therapies and immunotherapies who may wish to consider building a market development strategy in this region. The report has been written by a highly experienced expert author (Tenured US Professor level, MD/Ph.D) who trained in China and is knowledgeable in C.diff, vaccinology/local issues.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.